SYRS logo

Syros Pharmaceuticals, Inc. (SYRS)

Profile

Full Name

Syros Pharmaceuticals, Inc.

Ticker

NASDAQ: SYRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 30, 2016

Indexes

Not included

Website

https://www.syros.com

Employees

68

Key Details

Price

$0.00(-51.52%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.94M(-33.23% YoY)

Annual EPS

-$5.81(+22.43% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.00
    SYRS price is $0.00

    30-Day Relative Volume

    0.16
    SYRS 30-day relative volume is 0.16

    Price Performance

    Price Most recent change

    -51.52%
    SYRS price was down -51.52% on Aug 15, 2025

    Price YTD change

    -99.3%
    SYRS price is down -99.3% since January 1st

    Price 1-year change

    -99.89%
    SYRS price is down -99.89% year-on-year

    Price 3-year change

    -99.98%
    SYRS price is down -99.98% over the past 3 years

    Price Range

    Price All-time high

    $243.75
    SYRS price is currently -100.00% below its historical high of $243.75

    Price 3-year low

    $0.00
    SYRS price is currently +700.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $42.93K
    SYRS market capitalization is $42.93 thousand

    Market cap 3-year change

    -99.92%
    SYRS market capitalization is down -99.92% over the past 3 years

    Market cap All-time high

    $840.53M
    SYRS market capitalization is currently -99.99% below its historical high of $840.53 million

    Market cap sector rank

    2.07%
    SYRS market capitalization is higher than 2.07% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.08%
    SYRS shares outstanding is up +0.08% year-on-year

    Shares Outstanding 3-Year Change

    +325.88%
    SYRS shares outstanding is up +325.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.15
    SYRS beta is 1.15

    200-day SMA

    $0.25
    SYRS price is currently -99.36% below its 200-day simple moving average

    50-day SMA

    $0.01
    SYRS price is currently -89.12% below its 50-day simple moving average

    RSI

    39.29
    SYRS 14-day relative strength index is 39.29

    Volume

    0.16
    SYRS 30-day relative volume is 0.16

    ATR

    $0.01
    SYRS average true range is $0.01

    10-day Historical Volatility

    1371.38%
    SYRS 10-day historical volatility is 1371.38%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.94M
    SYRS annual revenue is $9.94 million

    Revenue Analysts estimate

    -
    SYRS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -33.23%
    SYRS annual revenue is down -33.23% year-on-year

    Revenue Sector rank

    47.86%
    SYRS annual revenue is higher than 47.86% of companies in Healthcare sector

    EPS

    EPS

    -$5.81
    SYRS annual earnings per share is -$5.81

    EPS Analysts estimate

    -$1.61
    SYRS annual earnings per share is currently +259.75% higher than the consensus analysts' forecast

    EPS 1-year change

    +22.43%
    SYRS annual earnings per share is up +22.43% year-on-year

    EPS Sector rank

    17.68%
    SYRS annual earnings per share is higher than 17.68% of companies in Healthcare sector

    Profit

    Gross profit

    $7.68M
    SYRS annual gross profit is $7.68 million

    Gross margin

    77.33%
    SYRS annual gross profit margin is 77.33%

    Operating profit

    -$126.50M
    SYRS annual operating income is -$126.50 million

    Operating margin

    -1273.14%
    SYRS annual operating profit margin is -1273.14%

    Net income

    -$164.57M
    SYRS annual net profit is -$164.57 million

    Net margin

    -1656.34%
    SYRS annual net profit margin is -1656.34%

    Expenses

    Total expenses

    $136.44M
    SYRS annual total expenses is $136.44 million

    Operating expenses

    $136.44M
    SYRS annual total operating expenses is $136.44 million

    Cost of goods sold

    $2.25M
    SYRS annual cost of goods sold is $2.25 million

    Selling, general & administrative expenses

    $28.28M
    SYRS annual SGA is $28.28 million

    Depreciation and amortization

    $2.25M
    SYRS annual depreciation & amortization is $2.25 million

    Interest expense

    $0.00
    SYRS annual interest expense is $0.00

    Income tax

    $0.00
    SYRS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$159.45M
    SYRS annual earnings before interest & taxes is -$159.45 million

    EBITDA

    -$157.19M
    SYRS annual EBITDA is -$157.19 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $168.17M
    SYRS annual total assets is $168.17 million

    Non current assets

    $23.19M
    SYRS annual long term assets is $23.19 million

    Current assets

    $144.98M
    SYRS annual total current assets is $144.98 million

    Cash and cash equivalents

    $139.53M
    SYRS annual cash & cash equivalents is $139.53 million

    Accounts receivable

    $0.00
    SYRS annual accounts receivable is $0.00

    Inventory

    $0.00
    SYRS annual inventory is $0.00

    Liabilities

    Total liabilities

    $151.51M
    SYRS annual total liabilities is $151.51 million

    Long term liabilities

    $114.83M
    SYRS annual total long term liabilities is $114.83 million

    Current liabilities

    $36.68M
    SYRS annual total current liabilities is $36.68 million

    Accounts payable

    $11.54M
    SYRS annual accounts payable is $11.54 million

    Debt

    Total debt

    $62.08M
    SYRS annual total debt is $62.08 million

    Total debt 1-year change

    -2.35%
    SYRS annual total debt is down -2.35% year-on-year

    Long term debt

    $53.08M
    SYRS annual long term debt is $53.08 million

    Short term debt

    $8.99M
    SYRS annual short term debt is $8.99 million

    Equity & Capital

    Shareholders equity

    $16.66M
    SYRS annual stockholders equity is $16.66 million

    Book value

    $16.66M
    SYRS annual book value is $16.66 million

    Retained earnings

    -$722.81M
    SYRS annual retained earnings is -$722.81 million

    Working capital

    $108.30M
    SYRS annual working capital is $108.30 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$109.71M
    SYRS annual cash flow from operations is -$109.71 million

    Cash from operations 1-year change

    +10.85%
    SYRS annual cash flow from operations is up +10.85% year-on-year

    Cash from investing

    $37.34M
    SYRS annual cash flow from investing activities is $37.34 million

    Cash from investing 1-year change

    -44.43%
    SYRS annual cash flow from investing activities is down -44.43% year-on-year

    Cash from financing

    $43.46M
    SYRS annual cash flow from financing activities is $43.46 million

    Cash from financing 1-year change

    -66.83%
    SYRS annual cash flow from financing activities is down -66.83% year-on-year

    CAPEX

    CAPEX

    $272.00K
    SYRS annual capital expenditures is $272.00 thousand

    CAPEX 1-year change

    -78.08%
    SYRS annual capital expenditures is down -78.08% year-on-year

    Free Cash Flow

    Free cash flow

    -$109.98M
    SYRS annual free cash flow is -$109.98 million

    Free cash flow 1-year change

    +11.53%
    SYRS annual free cash flow is up +11.53% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    77.33%
    SYRS annual gross profit margin is 77.33%

    Operating margin

    -1273.14%
    SYRS annual operating profit margin is -1273.14%

    Net margin

    -1656.34%
    SYRS annual net profit margin is -1656.34%

    ROA & ROE

    ROA

    -79.76%
    SYRS annual return on assets is -79.76%

    ROE

    -227.95%
    SYRS annual return on equity is -227.95%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SYRS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SYRS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.00
    SYRS price to book ratio is 0.00

    PB ratio Sector rank

    17.54%
    SYRS price to book ratio is higher than 17.54% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.11
    SYRS price to sales ratio is 0.11

    PS ratio Sector rank

    4.66%
    SYRS price to sales ratio is higher than 4.66% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.99M
    SYRS enterprise value is $1.99 million

    Enterprise value Sector rank

    18.36%
    SYRS enterprise value is higher than 18.36% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.02
    SYRS EV/EBITDA is -0.02

    EV/EBITDA Sector rank

    60.23%
    SYRS EV/EBITDA is higher than 60.23% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.95
    SYRS annual current ratio is 3.95

    Quick ratio

    3.95
    SYRS annual quick ratio is 3.95

    Leverage

    Debt to equity

    3.73
    SYRS annual debt to equity ratio is 3.73

    Interest coverage ratio

    -
    SYRS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    SYRS piotroski f-score value is unknown

    Altman Z-Score

    -8.31
    SYRS altman z-score is -8.31

    Analyst ratings

    Recent major analysts updates

    Nov 13, 24 TD Cowen
    Hold
    Nov 13, 24 JMP Securities
    Market Perform
    Nov 13, 24 HC Wainwright & Co.
    Neutral
    Nov 13, 24 Brookline Capital
    Hold
    Nov 1, 24 HC Wainwright & Co.
    Buy
    Aug 13, 24 Piper Sandler
    Overweight
    Aug 13, 24 JMP Securities
    Market Outperform
    Aug 13, 24 HC Wainwright & Co.
    Buy
    Aug 1, 24 HC Wainwright & Co.
    Buy
    Jun 26, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with SYRS included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Syros Pharmaceuticals, Inc.?
    • Does Syros Pharmaceuticals, Inc. pay dividends?
    • What sector is Syros Pharmaceuticals, Inc. in?
    • What industry is Syros Pharmaceuticals, Inc. in?
    • What country is Syros Pharmaceuticals, Inc. based in?
    • When did Syros Pharmaceuticals, Inc. go public?
    • Is Syros Pharmaceuticals, Inc. in the S&P 500?
    • Is Syros Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Syros Pharmaceuticals, Inc. in the Dow Jones?
    • When was Syros Pharmaceuticals, Inc.'s last earnings report?
    • When does Syros Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Syros Pharmaceuticals, Inc.?

    The ticker symbol for Syros Pharmaceuticals, Inc. is NASDAQ:SYRS

    Does Syros Pharmaceuticals, Inc. pay dividends?

    No, Syros Pharmaceuticals, Inc. does not pay dividends

    What sector is Syros Pharmaceuticals, Inc. in?

    Syros Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Syros Pharmaceuticals, Inc. in?

    Syros Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Syros Pharmaceuticals, Inc. based in?

    Syros Pharmaceuticals, Inc. is headquartered in United States

    When did Syros Pharmaceuticals, Inc. go public?

    Syros Pharmaceuticals, Inc.'s initial public offering (IPO) was on June 30, 2016

    Is Syros Pharmaceuticals, Inc. in the S&P 500?

    No, Syros Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Syros Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Syros Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Syros Pharmaceuticals, Inc. in the Dow Jones?

    No, Syros Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Syros Pharmaceuticals, Inc.'s last earnings report?

    Syros Pharmaceuticals, Inc.'s most recent earnings report was on March 31, 2025

    When does Syros Pharmaceuticals, Inc. report earnings?

    The date for Syros Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page